threonine has been researched along with Acquired Immune Deficiency Syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bayle, G; Beytout, J; Champredon, C; Charrier, S; Cormerais, L; Gourdon, F; Grizard, J; Lamain, S; Laurichesse, H; Laveran, H; Rochon, C; Tauveron, I; Thieblot, P | 1 |
Bonavida, B; Mori, S; Murakami-Mori, K; Nakamura, S | 1 |
2 other study(ies) available for threonine and Acquired Immune Deficiency Syndrome
Article | Year |
---|---|
Threonine and methionine are limiting amino acids for protein synthesis in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amino Acids; Amino Acids, Essential; Glucose; Humans; Insulin; Kinetics; Male; Methionine; Nutritional Requirements; Protein Biosynthesis; Threonine | 1998 |
Implication of TNF receptor-I-mediated extracellular signal-regulated kinases 1 and 2 (ERK1/2) activation in growth of AIDS-associated Kaposi's sarcoma cells: a possible role of a novel death domain protein MADD in TNF-alpha-induced ERK1/2 activation in K
Topics: Acquired Immunodeficiency Syndrome; Antibodies, Monoclonal; Antigens, CD; Calcium-Calmodulin-Dependent Protein Kinases; Carrier Proteins; Cell Division; Dactinomycin; Death Domain Receptor Signaling Adaptor Proteins; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Growth Inhibitors; Growth Substances; Guanine Nucleotide Exchange Factors; Humans; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Sarcoma, Kaposi; Threonine; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Tyrosine | 1999 |